Novel Indications Trials are underway to assess GLP-1 efficacy in areas such as sleep apnea, cardiovascular risk reduction, neurodegenerative diseases (e.g., Alzheimers, Parkinsons), and womens health conditions like PCOS
Furthermore, despite the 5 % weight loss at week nine, subjects taking inulin ate significantly less (~270 kcal less, p = 0.027) at the follow-up ad libitum meal, with no consequent rebound in food intake at the 18 week visit despite a total 7 % weight loss in the inulin group, suggesting that inulins effect on weight management is mediated via appetite modulation
To solve this, we use advanced delivery systems
The medication is commonly used alongside metformin, with the combination often providing complementary mechanisms of action for improved glycemic control